66 related articles for article (PubMed ID: 2848556)
1. Characterization of murine monoclonal antibodies to HIV-1 induced by synthetic peptides.
Durda PJ; Leece B; Jenoski A; Rabin H; Fisher A; Wong-Staal F
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):331-42. PubMed ID: 2848556
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus gp120 glycoprotein detected by a monoclonal antibody to a synthetic peptide.
Chanh TC; Kennedy RC; Alderete BE; Kanda P; Eichberg JW; Dreesman GR
Eur J Immunol; 1986 Nov; 16(11):1465-8. PubMed ID: 3023102
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibodies against a synthetic peptide from human immunodeficiency virus type 1 Nef protein.
Steinaa L; Wulff AM; Saermark T
Hybridoma; 1994 Oct; 13(5):383-8. PubMed ID: 7860095
[TBL] [Abstract][Full Text] [Related]
4. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera.
Schneider T; Harthus HP; Hildebrandt P; Niedrig M; Bröker M; Weigelt W; Beck A; Pauli G
AIDS Res Hum Retroviruses; 1991 Jan; 7(1):37-44. PubMed ID: 1707640
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide.
Durda PJ; Bacheler L; Clapham P; Jenoski AM; Leece B; Matthews TJ; McKnight A; Pomerantz R; Rayner M; Weinhold KJ
AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1115-23. PubMed ID: 1702301
[TBL] [Abstract][Full Text] [Related]
6. Production of a nef-specific monoclonal antibody by the use of a synthetic peptide.
De Santis R; Anastasi AM; Marcolini S; Valesini G; Pezzella M; Vonesch N; Sturchio E; Mele A
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):315-21. PubMed ID: 2064828
[TBL] [Abstract][Full Text] [Related]
7. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46.
Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF
J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272
[TBL] [Abstract][Full Text] [Related]
8. HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
Laman JD; Schellekens MM; Paddenburg D; Tersmette M; Langedijk JP; Boersma WJ; Claassen E
Year Immunol; 1993; 7():63-8. PubMed ID: 7690509
[No Abstract] [Full Text] [Related]
9. Monoclonal anti-idiotypic antibody mimicking the principal neutralization site in HIV-1 GP120 induces HIV-1 neutralizing antibodies in rabbits.
Fung MS; Sun CR; Liou RS; Gordon W; Chang NT; Chang TW; Sun NC
J Immunol; 1990 Oct; 145(7):2199-206. PubMed ID: 2398276
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses of chimpanzees immunized with synthetic peptides corresponding to full-length V3 hypervariable loops of HIV-1 envelope glycoproteins.
Neurath AR; Jiang S; Strick N; Kolbe H; Kieny MP; Muchmore E; Girard M
AIDS Res Hum Retroviruses; 1991 Oct; 7(10):813-23. PubMed ID: 1720628
[TBL] [Abstract][Full Text] [Related]
11. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a mouse/human chimeric monoclonal antibody (C beta 1) to a principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein.
Matsushita S; Maeda H; Kimachi K; Eda Y; Maeda Y; Murakami T; Tokiyoshi S; Takatsuki K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1107-15. PubMed ID: 1380258
[TBL] [Abstract][Full Text] [Related]
13. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.
Sun NC; Ho DD; Sun CR; Liou RS; Gordon W; Fung MS; Li XL; Ting RC; Lee TH; Chang NT
J Virol; 1989 Sep; 63(9):3579-85. PubMed ID: 2474670
[TBL] [Abstract][Full Text] [Related]
14. Confronting the hypervariability of an immunodominant epitope eliciting virus neutralizing antibodies from the envelope glycoprotein of the human immunodeficiency virus type 1 (HIV-1)--II. Synthetic peptides linked to HIV-1 carrier proteins gag and nef.
Neurath AR; Strick N; Kolbe H; Kieny MP; Girard M; Jiang S
Mol Immunol; 1991 Sep; 28(9):965-73. PubMed ID: 1717841
[TBL] [Abstract][Full Text] [Related]
15. Engineering and functional evaluation of a single-chain antibody against HIV-1 external glycoprotein gp120.
Wang HW; Cole D; Jiang WZ; Jin HT; Fu N; Chen ZL; Jin NY
Clin Exp Immunol; 2005 Jul; 141(1):72-80. PubMed ID: 15958072
[TBL] [Abstract][Full Text] [Related]
16. Anti-P30-52 monoclonal antibody cross-reacted to Env V3 and inhibited the viral multiplication of HIV-1-infected MT-4 cells.
Ota A; Bautista AN; Yadav ML; Ueda S
Hybridoma; 1999 Apr; 18(2):139-47. PubMed ID: 10380013
[TBL] [Abstract][Full Text] [Related]
17. Characterization and epitope mapping of a human monoclonal antibody reactive with the envelope glycoprotein of human immunodeficiency virus.
Banapour B; Rosenthal K; Rabin L; Sharma V; Young L; Fernandez J; Engleman E; McGrath M; Reyes G; Lifson J
J Immunol; 1987 Dec; 139(12):4027-33. PubMed ID: 2447158
[TBL] [Abstract][Full Text] [Related]
18. A chimeric mouse-human antibody that retains specificity for HIV gp120 and mediates the lysis of HIV-infected cells.
Liou RS; Rosen EM; Fung MS; Sun WN; Sun C; Gordon W; Chang NT; Chang TW
J Immunol; 1989 Dec; 143(12):3967-75. PubMed ID: 2480382
[TBL] [Abstract][Full Text] [Related]
19. Fine mapping of HIV-1 Nef-epitopes by monoclonal antibodies.
Siakkou H; Jahn S; Kienzle N; Ulrich R; Grötzinger C; Schneider T; Kohleisen B; Pauli G; Spohn R; Jung G
Arch Virol; 1993; 128(1-2):81-95. PubMed ID: 7678193
[TBL] [Abstract][Full Text] [Related]
20. Peptides mimicking selected disulfide loops in HIV-1 gp120, other than V3, do not elicit virus-neutralizing antibodies.
Neurath AR; Strick N; Fields R; Jiang S
AIDS Res Hum Retroviruses; 1991 Aug; 7(8):657-62. PubMed ID: 1718344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
